Nowadays, for example, nivolumab (an anti-PD-1 antibody) has been approved by the FDA to treat colorectal cancer, hepatocellular carcinoma (HCC), melanoma, lung cancer, and several other cancers [15, 16]. Here, PDCD1 is linked to colorectal cancer.